Bionano Genomics Inc logo

BNGOU - Bionano Genomics Inc News Story

$7.55 0.2  2.4%

Sector
Healthcare
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6853

Bionano Genomics Announces Presentations on Optical Genome Mapping at the American Association for Cancer Research (AACR) Annual Meeting 2021

Wed 7th April, 2021 9:30pm
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210407:nGNX9ZXP47&default-theme=true


SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq:
BNGO) today announced that multiple studies on the detection of structural
variants using Bionano’s optical genome mapping, including a Spotlight
Presentation, will be presented at the American Association for Cancer
Research (AACR) Annual Meeting 2021, which is being held in a virtual format
April 10-15, 2021.

Details of the presentations are as follows:

Title of Spotlight Presentation: “Optical Genome Mapping: Unrivaled
Structural Variant Detection for Cancer Research and Precision Medicine” -
Dr. Yannick Delpu, Bionano Genomics
“Optical Genome Mapping Uncovers Novel Structural Variants Associated With
Drug Sensitivities In Leukemias” - Dr. Darren Finlay, Sanford Burnham Prebys
Medical Discovery Institute, La Jolla, CA
Presentation Time: April 14, 2021, 1:00 - 2:00 PM EDT
Session Category: ESP.15
(https://www.globenewswire.com/Tracker?data=CwCPGJQuGJJX3aiKOp6drfhU0DkWHM6dee9J_tcVaJhesFw73UuyWbohWhUQfTUJh3VDKoijwxCI63fZCEmrMEG09UTcWTkUJP4_pD7ilZ6FbgEQqhyUuEjFyyA15Z3S)

Title: Detection of Structural Variation and Analysis on HuKemia Models by
Using Bionano Optical Mapping
Session Category: Molecular and Cellular Biology/Genetics
Session Title: Genomic Profiling of Tumors
Permanent Abstract Number: 2234
(https://www.globenewswire.com/Tracker?data=tioHCG4YqmKWoSYvEgGOHLvYM9uc74fPJb7xGrHeUgTxQPaBa2TRKUlxcbt7iISz1nPwTqfmiNx8Bz639OF7GVcX-UZaxTGsFeTXuZa4H13nIj7sKZ8hRljBvyT2sdEf)

Authors: Xiaobo Chen, Huan Tian, Wubin Qian, Henry Q. Li, Sheng Guo. Crown
Bioscience Inc, Suzhou, China, Crown Bioscience Inc, San Diego, CA

More details can be found
at https://www.aacr.org/meeting/aacr-annual-meeting-2021/.

About Bionano Genomics

Bionano is a genome analysis company providing tools and services based on its
Saphyr system to scientists and clinicians conducting genetic research and
patient testing, and providing diagnostic testing for those with autism
spectrum disorder (ASD) and other neurodevelopmental disabilities through its
Lineagen business. Bionano’s Saphyr system is a research use only platform
for ultra-sensitive and ultra-specific structural variation detection that
enables researchers and clinicians to accelerate the search for new
diagnostics and therapeutic targets and to streamline the study of changes in
chromosomes, which is known as cytogenetics. The Saphyr system is comprised of
an instrument, chip consumables, reagents and a suite of data analysis tools.
Bionano provides genome analysis services to provide access to data generated
by the Saphyr system for researchers who prefer not to adopt the Saphyr system
in their labs. Lineagen has been providing genetic testing services to
families and their healthcare providers for over nine years and has performed
over 65,000 tests for those with neurodevelopmental concerns. For more
information, visit www.bionanogenomics.com or www.lineagen.com.

CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionanogenomics.com

Investor Relations and 
Media Contact:
Amy Conrad
Juniper Point
+1 (858) 366-3243
amy@juniper-point.com

(https://www.globenewswire.com/NewsRoom/AttachmentNg/3253163c-a161-4291-875a-c40a9683c9f8)



GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.